September 19, 2025

My brother takes precautions to safely navigate his home – Myasthenia Gravis News

September 19, 2025

Johnson & Johnson Unleashes Triple Threat: Bladder Cancer Breakthrough, Psoriasis Game-Changer, and Myasthenia Gravis Milestone Signal New Pharma Era – FinancialContent

September 19, 2025

Johnson & Johnson receives positive CHMP opinion of nipocalimab to treat a broad population of antibody-positive patients living with generalised myasthenia gravis (gMG) – The Manila Times

September 18, 2025

Vor Bio to present phase 3 data on telitacicept for myasthenia gravis By Investing.com – Investing.com South Africa

September 18, 2025

Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis – The American Journal of Managed Care® (AJMC®)